Browse Diagnostic reagents industry topic

Articles

1-100 out of 100 article(s)

Title	Author	Type	Date	Words
ImClone Systems Reports Second Quarter 2008 Financial Results.		Financial report	Jul 24, 2008	4290
Quidel Reports Second Quarter 2008 Results.		Financial report	Jul 23, 2008	1404
ImClone Systems to Host Second Quarter 2008 Financial Results Conference Call.			Jul 18, 2008	487
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer.			Jul 16, 2008	2133
ImClone Announces Changes in Commercial Organization Leadership.			Jul 14, 2008	1899
Quidel to Hold 2008 Second Quarter Conference Call on July 23, 2008.			Jul 9, 2008	378
Phase 2 Study Of IMC-A12 for Advanced Soft Tissue Sarcoma Opens for Patient Enrollment.			Jul 7, 2008	770
NeoPharm Receives NASDAQ Notice.			Jun 26, 2008	641
IMC-A12 Plus Temsirolimus Clinical Trial for Advanced Cancer Opens for Patient Enrollment.			Jun 25, 2008	1173
Signature Reports Investment in Company and Appointment of New Chairman of Board of Directors.			Jun 24, 2008	434
NeoPharm Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market.			Jun 12, 2008	581
English Court Orders Disclosure Of Customer Information At Interim Stage.			Jun 10, 2008	880
ImClone Systems to Present at the Goldman Sachs 29th Annual Global Healthcare Conference.		Conference news	Jun 6, 2008	417
Zacks Analyst Blog Highlights: Genentech, ImClone Systems, Phoenix Companies, Tyco Electronics and Agilysys.			Jun 5, 2008	1049
ImClone Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations.			Jun 2, 2008	2150
New Analyses of Pivotal Phase 3 Study of ERBITUX(R) Demonstrate Enhanced Efficacy in First-Line Metastatic Colorectal Cancer Patients with Wild-Type K-Ras Biomarker.			Jun 1, 2008	2178
RTOG Study: Adding Cetuximab to Chemotherapy and Radiotherapy Leads to Improved Outcome for Lung Cancer Patients.		Clinical report	May 31, 2008	2392
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer.		Clinical report	May 31, 2008	2583
ImClone to Host Investor Reception on June 1, 2008 to Discuss Data Presented at the American Society of Clinical Oncology Annual Meeting.			May 30, 2008	1796
The Sidewinder Report: Traders Repositioning Anheuser-Busch Options?			May 30, 2008	134
NeoPharm Announces Execution of a Letter of Intent with SIRO ClinPharm for a planned Confirmatory Phase III Trial for Cintredekin Besudotox (IL13-PE38QQR).			May 22, 2008	947
NeoPharm Enrolls First Patient in Phase I Trial for Patients with Metastatic Solid Cancer.			May 21, 2008	819
Quidel and Prodesse Announce Flu and RSV Molecular Partnership.			May 20, 2008	1066
NeoPharm, Inc. to Attend the Barrington Research Healthcare Conference.		Conference news	May 20, 2008	101
Phase I/II Studies of IMC-A12 in Pancreatic Cancer Open for Patient Enrollment.			May 20, 2008	1092
ImClone Systems to Present at the 2008 Citi Investment Research Global Health Care Conference.		Conference news	May 19, 2008	419
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting.		Clinical report	May 16, 2008	1505
Significant Data on ERBITUX(R) (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinical Oncology 2008 Annual Meeting.			May 16, 2008	1736
Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment.		Report	May 13, 2008	1018
NeoPharm, Inc. Announces First Quarter 2008 Financial Results.		Financial report	May 12, 2008	1276
ImClone Systems to Present at the Bank of America 2008 Healthcare Conference.		Conference news	May 12, 2008	417
NEOPHARM REPORTS 2007 4TH QTR NET LOSS OF $1.1 MILLION.		Financial report	May 1, 2008	1092
ImClone Systems Reports First Quarter 2008 Financial Results.		Financial report	Apr 24, 2008	3527
Quidel Reports First Quarter 2008 Results.		Financial report	Apr 23, 2008	1230
ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer.			Apr 22, 2008	1047
ImClone Systems to Host First Quarter 2008 Financial Results Conference Call.			Apr 18, 2008	486
Research and Markets: New Analysis of ImClone Systems - Researches and Develops Growth Factor Blockers and Anti-Cancer Vaccines.			Apr 17, 2008	198
Quidel to Hold 2008 First Quarter Conference Call on April 23, 2008.			Apr 9, 2008	423
Phase II Study of IMC-A12 for Advanced Head and Neck Cancer Commences Patient Enrollment.		Clinical report	Apr 9, 2008	1518
NeoPharm Enrolls First Patients in Phase II Metastatic Breast Cancer Study.			Mar 31, 2008	769
ImClone Appoints Kenneth J. Zuerblis Chief Financial Officer.			Mar 31, 2008	704
NeoPharm, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results.		Financial report	Mar 27, 2008	1470
Aureon Laboratories Names Ana I. Stancic Chief Financial Officer.			Mar 17, 2008	388
ImClone Systems to Present at the Cowen and Company 28th Annual Health Care Conference.		Conference news	Mar 11, 2008	417
Phase I/II Studies of IMC-A12 in Pediatric Cancer Patients Commence Enrollment.			Mar 5, 2008	1019
Quidel Corporation and Susie's Cause Partner in Colorectal Cancer Awareness Event.			Mar 4, 2008	1186
Cylex ImmuKnow test may identify kidney transplant patients at risk for early acute rejection.			Mar 1, 2008	282
FDA Grants CLIA Waiver for Quidel's QuickVue(R) RSV Test.			Feb 29, 2008	782
Phase II Study of IMC-1121B for Advanced Liver Cancer Commences Patient Enrollment.			Feb 22, 2008	789
Quidel Reports Fourth Quarter and Full Year 2007 Results.			Feb 21, 2008	1462
Quidel to Hold 2007 Fourth Quarter and Year-End Financial Results Conference Call on February 21, 2008.			Feb 11, 2008	359
ImClone Systems to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference.		Conference news	Feb 4, 2008	417
ImClone Systems Reports Fourth Quarter and Full Year 2007 Financial Results.		Financial report	Jan 31, 2008	3316
Robert Connelly Joins Pulmatrix as CEO.			Jan 22, 2008	272
ImClone Systems to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call.			Jan 21, 2008	488
Quidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics.			Jan 15, 2008	965
ImClone Systems to Present at the Stanford Group Company 13th Annual Healthcare Conference.		Conference news	Jan 14, 2008	417
Third Wave Responds to Court Ruling on Anti-Trust Claims in Digene Suit.			Jan 14, 2008	623
ImClone Systems to Present at the 26th Annual JPMorgan Healthcare Conference.		Conference news	Jan 3, 2008	414
NEOPHARM Announces IND Filing for Novel Liposomal Delivery System of Docetaxel.			Jan 2, 2008	584
Director index.			Jan 1, 2008	569
NEOPHARM, Inc. Receives NASDAQ Notification.			Dec 28, 2007	605
Company index.			Dec 22, 2007	236
Phase II Study of IMC-1121B for Advanced Malignant Melanoma Commences Patient Enrollment.		Clinical report	Dec 13, 2007	658
ImClone and Sanofi-Aventis Settle Patent Litigation with Yeda Research and Development Corporation.			Dec 7, 2007	1352
Quidel Corporation and Roche to Collaborate in Pilot Program for Influenza Management in U.S. This Flu Season.			Dec 6, 2007	935
Confident results.		Brief article	Dec 1, 2007	71
Published Data Suggest That ERBITUX(R) Enables Complete Surgical Resection of Colorectal Liver Metastases in Patients Previously Refractory to Conventional Systemic Therapy.			Nov 29, 2007	1802
ImClone Systems to Present at the Piper Jaffray Nineteenth Annual Healthcare Conference.		Conference news	Nov 20, 2007	416
ImClone Systems to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference.		Conference news	Nov 20, 2007	417
NCCN Receives Major Grant for Anti-Cancer Drug Study.		Report	Nov 15, 2007	634
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer.			Nov 14, 2007	1933
NEOPHARM, Inc. Announces Third Quarter 2007 Financial Results.		Financial report	Nov 8, 2007	1153
Dyax Corp. Announces Extension of Antibody Library Collaboration with ImClone Systems.			Nov 8, 2007	734
ImClone Systems to Present at the Bear Stearns 2007 SMid-Cap Conference.		Conference news	Nov 7, 2007	414
Dr. Kenneth F. Buechler Appointed to Quidel Corporation Board of Directors.			Nov 6, 2007	727
Hanna helps Ortho-Clinical change lives.	Farrell, Patrick	Personal account	Nov 1, 2007	630
ImClone Systems to Present at the Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference.		Conference news	Oct 30, 2007	417
1000th Patient Enrolls in National "LORHAN" Head and Neck Cancer Registry.			Oct 29, 2007	911
ImClone Systems Reports Third Quarter 2007 Financial Results.		Financial report	Oct 25, 2007	3387
Quidel Reports Strong Third Quarter Results.		Financial report	Oct 24, 2007	1478
Insightful Corporation Announces 2007 Impact Award Winners.		Awards list	Oct 22, 2007	590
ImClone and Bristol-Myers Squibb Announce Joint Agreement with Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan.			Oct 17, 2007	1831
Quidel to Hold 2007 Third Quarter Financial Results Conference Call on October 24.			Oct 17, 2007	359
Adventist Health System, Largest Not-for-Profit Health System in the U.S., Selects Quidel as Flu Test Supplier.			Oct 16, 2007	952
ImClone Systems to Host Third Quarter 2007 Financial Results Conference Call.			Oct 12, 2007	458
Biothera Initiates Phase Ib/IIa Clinical Trial with Imprime PGG and Erbitux in Metastatic Colorectal Cancer Patients.			Oct 9, 2007	336
Physicians More Appropriately Prescribe Treatment after Rapid Flu and RSV Testing of Pediatric Patients.			Oct 8, 2007	896
Use of Quidel QuickVue(R) Rapid Flu Test in Nursing Homes Allows for More Rapid Recognition of Outbreaks and Appropriate Therapies.			Oct 8, 2007	967
Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports Use as a Single Agent in Patients with Advanced Colorectal Cancer.			Oct 3, 2007	1650
Third Wave: Court Denies Digene Request, Reaffirms Markman Order in Third Wave-Digene Case.			Sep 27, 2007	486
Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG.			Sep 26, 2007	996
NEOPHARM Announces Management Appointment.			Sep 24, 2007	671
ImClone Systems Expands IMC-A12 Development with Ten New Planned Clinical Trials.			Sep 20, 2007	689
Quidel to Present at the UBS 2007 Global Life Sciences Conference.		Conference news	Sep 19, 2007	318
Biothera's Imprime PGG Increases Efficacy of Erbitux against Non-Small Cell Lung Cancer, Study Finds.			Sep 11, 2007	959
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study.		Clinical report	Sep 11, 2007	2277
Repligen settles with ImClone in Erbitux lawsuit.			Aug 1, 2007	306
Court dismisses Gen-Probe court action against Digene.			Jul 1, 2007	395
Ortho-Clinical issues voluntary recall for cardiac marker.			May 7, 2007	357

Subtopics (39)

Articles